share_log

爱朋医疗(300753.SZ)：在脑电技术领域，公司是国内少数掌握麻醉深度指数监测技术的企业之一

Jiangsu Apon Medical Technology (300753.SZ): In the field of electroencephalogram technology, the company is one of the few domestic enterprises that master the technology of monitoring the depth of anesthesia index.

Gelonghui Finance ·  Aug 5 04:25

Jiangsu Apon Medical Technology (300753.SZ) stated on the investor interaction platform that it is a national specialized, special, and new small-and-medium enterprise. In the field of pain management, the company is among the first domestic enterprises to master a series of core technologies, including high-precision drug liquid infusion technology, all-around safety monitoring technology, pain management information platform technology, etc. It is also the only enterprise unit that has participated in the formulation of industry standards for "portable electric infusion pumps." In the field of nasal and upper airway management, the company is one of the first enterprises to enter the field of nasal flushing, and it pioneered the new concept of "sequential treatment" for nasal cleaning, as well as innovatively developed nasal spray for different types of rhinitis and stages of the disease to meet the personalized and precise treatment needs of different rhinitis patients. In the field of electroencephalography technology, the company is one of the few domestic enterprises that have mastered the technology of monitoring the depth of anesthesia index. The new-generation ADM series of anesthesia depth monitors, which have just been awarded with three types of certifications, innovate the CSI index of electroencephalogram (EEG) spectral analysis charts and data such as blood oxygen and pulse rate, and have functions such as EEG spectral analysis, anesthesia depth evaluation, anti-electrosurgery knife, etc. It is one of the company's important products in the layout of electroencephalography technology. The company will continue to focus on the research and development and construction of pain management, nasal and upper airway management, and electroencephalography technology platforms and continuously improve the company's technological barriers and moats.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment